ID26341A - PROCESS FOR PROVIDING DOSAGE STABLE COMPOSITION OF ANTI-INFECTION AND MICROORGANISM SUBSTANCE AS ACTIVE DRUG MATERIALS - Google Patents

PROCESS FOR PROVIDING DOSAGE STABLE COMPOSITION OF ANTI-INFECTION AND MICROORGANISM SUBSTANCE AS ACTIVE DRUG MATERIALS

Info

Publication number
ID26341A
ID26341A IDW991648A ID991648A ID26341A ID 26341 A ID26341 A ID 26341A ID W991648 A IDW991648 A ID W991648A ID 991648 A ID991648 A ID 991648A ID 26341 A ID26341 A ID 26341A
Authority
ID
Indonesia
Prior art keywords
infection
active drug
stable composition
drug materials
providing dosage
Prior art date
Application number
IDW991648A
Other languages
Indonesian (id)
Inventor
Bansal Yatish Kumar
Khamar Bakulesh Mafalal
Modi Rajiv Indravadam
Original Assignee
Cadila Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806489.2A external-priority patent/GB9806489D0/en
Application filed by Cadila Pharm Ltd filed Critical Cadila Pharm Ltd
Publication of ID26341A publication Critical patent/ID26341A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDW991648A 1998-03-27 1998-04-03 PROCESS FOR PROVIDING DOSAGE STABLE COMPOSITION OF ANTI-INFECTION AND MICROORGANISM SUBSTANCE AS ACTIVE DRUG MATERIALS ID26341A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LK1644598 1998-03-27
GBGB9806489.2A GB9806489D0 (en) 1998-03-27 1998-03-27 The process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent/agents and micro organisms as active ingredients
PCT/IB1998/000445 WO1999049875A1 (en) 1998-03-27 1998-04-03 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients

Publications (1)

Publication Number Publication Date
ID26341A true ID26341A (en) 2000-12-14

Family

ID=26313367

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991648A ID26341A (en) 1998-03-27 1998-04-03 PROCESS FOR PROVIDING DOSAGE STABLE COMPOSITION OF ANTI-INFECTION AND MICROORGANISM SUBSTANCE AS ACTIVE DRUG MATERIALS

Country Status (9)

Country Link
EP (1) EP0998295A1 (en)
JP (1) JP2002516616A (en)
AP (1) AP9901724A0 (en)
AU (1) AU770024B2 (en)
CA (1) CA2291780A1 (en)
EA (1) EA002148B1 (en)
ID (1) ID26341A (en)
UA (1) UA59394C2 (en)
WO (1) WO1999049875A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227235B2 (en) * 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
US20130131033A1 (en) * 2010-01-13 2013-05-23 Toyochem Laboratories Pharmaceutical composition for treatment of respiratory tract infections
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
MX2021009755A (en) * 2019-02-13 2021-11-17 Iterum Therapeutics International Ltd Combinations of beta-lactam compounds and probenecid and uses thereof.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703360L (en) * 1987-08-31 1989-03-01 Lejus Medical Ab GRANULATED PRODUCTS (III)

Also Published As

Publication number Publication date
UA59394C2 (en) 2003-09-15
CA2291780A1 (en) 1999-10-07
WO1999049875A1 (en) 1999-10-07
AU770024B2 (en) 2004-02-12
AU6415698A (en) 1999-10-18
AP9901724A0 (en) 1999-12-31
EA002148B1 (en) 2001-12-24
EP0998295A1 (en) 2000-05-10
JP2002516616A (en) 2002-06-04
EA199900938A1 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
EE04238B1 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for their preparation, pharmaceutical compositions containing said therapeutically active substances and use of said active compounds in therapy
US4732892A (en) L-α-amino acids as transdermal penetration enhancers
ATE329897T1 (en) COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE SUBSTANCES
DE69531741D1 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
HUP9801331A3 (en) Tricyclic amide and urea derivatives useful for inhibition of g-protein function and for treatment of proliferative diseases, novel tricyclic amide and urea derivatives, use thereof, pharmaceutical compositions containing these compounds as active ...
MA26563A1 (en) THERAPEUTICALLY ACTIVE COMPOUNDS CONTAINING INDAZOLE AS A BIOISOSTERIC REPLACEMENT OF CATECHOL, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
DE69430132D1 (en) PERNASAL COMPOSITION AND PERNASALE PREPARATION CONTAINING IT
ID26237A (en) DELIVERY OF AEROSOLISATION ACTIVE SUBSTANCE
EE04399B1 (en) Spiroazabicyclic Heterocyclic Compounds, Process for their Preparation, Pharmaceutical Compositions Containing Them and Their Use in Therapy
BR0009830A (en) Skin care compositions containing a combination of active substances for skin care
EE03292B1 (en) Multiple drug formulation containing a proton pump inhibitor and process for its preparation
ATE428371T1 (en) BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF ENCLOSED SUBSTANCES
TR200100144T2 (en) Pharmaceutical aerosol formulation
EE03105B1 (en) Formulations containing a pharmacologically ionizable active ingredient and the process for their preparation
DK1069892T3 (en) Humidity activatable therapeutic system
WO1996026739A1 (en) Use of protealytic enzymes in the treatment of insect bites
PT1017392E (en) FORMULATION OF MEDICINAL PRODUCTS WITH CONTROLLED LIBERATION OF THE ACTIVE SUBSTANCE
ID26341A (en) PROCESS FOR PROVIDING DOSAGE STABLE COMPOSITION OF ANTI-INFECTION AND MICROORGANISM SUBSTANCE AS ACTIVE DRUG MATERIALS
SE9704400D0 (en) Porous inorganic particles as carriers for drug substances
HU905967D0 (en) Process for producing pharmaceutical preparatives containing heterocyclic compounds as active substance and process for producing these new active substances
EP0418341A4 (en) Percutaneous drug delivery system
HUP0401013A3 (en) Active substance combination for medicamentous therapy of nicotine dependency and pharmaceutical composition containing it
IT1301969B1 (en) SUCRALPHATE DRY GRANULAR AND POROUS GEL PROCEDURE FOR ITS PREPARATION, AND SOLID PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
NO983098D0 (en) Skin Adhesive Pharmaceutical Preparation, especially Transdermal Therapeutic System for Release of 17-Beta-Estradiol to the Human Organism